Exchange Traded Concepts, LLC Bristol Myers Squibb CO Transaction History

Exchange Traded Concepts, LLC

$4.74 Billion
Q4 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 22,583 shares of BMY stock, worth $1.33 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

22,583

Previous 26,468 14.68%

Holding current value

$1.33 Million

Previous $1.37 Million 6.72%

% of portfolio

0.03%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$51.92 - $59.94 $201,709 - $232,866	-3,885 Reduced 14.68%	22,583 $1.28 Million
Q3 2024 Oct 10, 2024	BUY	$39.66 - $51.75 $161,178 - $210,312	4,064 Added 18.14%	26,468 $1.37 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $7,446 - $9,803	-185 Reduced 0.82%	22,404 $930,000
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $287,927 - $326,454	-6,001 Reduced 20.99%	22,589 $1.23 Million
Q4 2023 Jan 05, 2024	SELL	$48.48 - $57.85 $16.5 Million - $19.7 Million	-341,185 Reduced 92.27%	28,590 $1.47 Million
Q3 2023 Oct 18, 2023	BUY	$57.89 - $64.73 $11.4 Million - $12.8 Million	197,106 Added 114.15%	369,775 $21.5 Million
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $3.29 Million - $3.66 Million	51,682 Added 42.72%	172,669 $11 Million
Q1 2023 Apr 12, 2023	SELL	$65.71 - $74.53 $4.08 Million - $4.62 Million	-62,016 Reduced 33.89%	120,987 $8.39 Million
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $419,303 - $496,514	-6,123 Reduced 3.24%	183,003 $13.2 Million
Q3 2022 Oct 07, 2022	BUY	$0.13 - $76.84 $11,181 - $6.61 Million	86,011 Added 83.41%	189,126 $13.4 Million
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $547,700 - $603,209	-7,542 Reduced 6.82%	103,115 $7.94 Million
Q1 2022 Apr 26, 2022	BUY	$61.48 - $73.72 $4.2 Million - $5.04 Million	68,396 Added 161.84%	110,657 $8.08 Million
Q4 2021 Jan 13, 2022	SELL	$53.63 - $62.52 $11.7 Million - $13.6 Million	-217,899 Reduced 83.76%	42,261 $2.64 Million
Q3 2021 Oct 18, 2021	BUY	$59.17 - $69.31 $5.98 Million - $7 Million	101,055 Added 63.51%	260,160 $15.4 Million
Q2 2021 Jul 30, 2021	BUY	$61.91 - $67.42 $2.71 Million - $2.96 Million	43,840 Added 38.03%	159,105 $10.6 Million
Q1 2021 Apr 20, 2021	SELL	$59.34 - $66.74 $532,576 - $598,991	-8,975 Reduced 7.22%	115,265 $7.28 Million
Q4 2020 Jan 19, 2021	BUY	$57.74 - $65.43 $6.74 Million - $7.64 Million	116,713 Added 1550.59%	124,240 $7.71 Million
Q3 2020 Oct 30, 2020	BUY	$57.43 - $63.64 $210,595 - $233,367	3,667 Added 95.0%	7,527 $454,000
Q2 2020 Jul 15, 2020	SELL	$54.82 - $64.09 $2.05 Million - $2.4 Million	-37,482 Reduced 90.66%	3,860 $227,000
Q1 2020 Apr 14, 2020	BUY	$46.4 - $67.43 $1.38 Million - $2 Million	29,731 Added 256.06%	41,342 $2.3 Million
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $571,377 - $745,310	11,611 New	11,611 $745,000

Others Institutions Holding BMY

# of Institutions

2,602

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Bristol Myers Squibb CO Transaction History